Creating A New Universe Of
Genetic Medicines
Revolutions in AI, biology and automation are enabling a new approach
to drug development. Deep Genomics is at the forefront.

AI-Powered Discovery Platform

The future of drug development will rely on artificial intelligence, because biology is too complex for humans to understand

Our AI platform rapidly directs us to the best drug candidates. It knows biology, from disease biomarkers all the way down to the level of DNA, RNA and the molecular machinery of the cell. Everyone at Deep Genomics uses the platform to do their work, and everyone participates in improving the platform. That includes our geneticists, biologists, chemists, toxicologists, clinicians and drug developers. Now, we’re creating and clinically evaluating new oligonucleotide therapies, designed up front to be effective and safe.

Learn More

Project Saturn

Smart drug design is about predicting outcomes up front. That's what our AI platform does best, and Saturn is the proof

In Project Saturn, we're using our platform to evaluate over 69 billion molecules against 1 million targets, in silico, to generate a library of 1000 compounds that are experimentally verified to manipulate cell biology as intended. Think of it as a toolkit for controlling cell biology along crucial pathways, rapidly unlocking therapies with greater potential.

Learn More

Join Us

We are looking for individuals who are inspired to join us in building a new kind of world-class genetic medicine company.

Learn More